Dimetilamilamina
Also known as 4-methylhexan-2-amine, methylhexamine, 1,3-dimethylamylamine, dimethylamylamine
Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.IUPAC_name
- 4-Methylhexan-2-amine
- Drug.image
- Geranamine.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Geranamine-3D-balls.png
- Drug.image_class2
- bg-transparent
- Drug.legal_AU
- S10
- Drug.legal_BR
- F2
- Drug.legal_US
- Unapproved drug; use in dietary supplements, food, or medicine is unlawful.
- Drug.routes_of_administration
- Nasal spray, oral
- Drug.elimination_half life
- ~8.5 hours
Article · Português
Dimetilamilamina, também conhecida como metilhexanamina, é uma amina alifática e um vasoconstritor utilizado como descongestionante nasal. Apesar de classificada como suplemento alimentar nos Estados Unidos, foi incluída pela Agência Mundial Antidoping em 2009 em sua lista de substâncias dopantes. Também por este motivo, não é comercializada nos Brasil.
Abstract from DBpedia / Wikipedia · CC BY-SA
Gallery (2)
Connections
Categories
AlkylaminesBodybuilding supplementsChemical pages without DrugBank identifierDecongestantsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by Eli Lilly and CompanyDrugs not assigned an ATC codeDrugs with non-standard legal statusECHA InfoCard ID from WikidataHepatotoxinsNorepinephrine-dopamine releasing agents